Etrasimod Arginine Blue Placebo clinical trials

C5041006 (APD334 202 or APD334-202EU): A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease

This study is testing a new medicine called etrasimod for people with moderate to severe Crohn's disease. Researchers want to see if it helps improve symptoms and gut health, and if it is safe to use.